Gap, Newmont,, Xenoport: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 8:40 a.m. in New York.

Bed Bath & Beyond Inc. (BBBY) gained 11 percent to $54.68. The home furnishings retailer forecast annual earnings of $3.38 to $3.53 a share. That compares with the average analyst projection of $3.33, Bloomberg data show.

Costco Wholesale Corp. (COST) rose 1.9 percent to $76.40. The largest U.S. warehouse-club chain reported total comparable sales rose 13 percent in March, beating the 7.4 percent estimate.

Gap Inc. (GPS) slipped 3.3 percent to $22.30. The largest U.S. apparel chain reported same-store sales in March were down 10 percent. The San Francisco-based company forecast first-quarter earnings will be less than the average analyst estimate of 44 cents a share.

Immucor Inc. (BLUD) climbed 7.3 percent to $21.43. The maker of products used to screen donated blood reported third- quarter earnings of 32 cents a share, beating the average analyst projection of 26 cents a share, according to data compiled by Bloomberg.

Immunogen Inc. (IMGN) advanced 7.2 percent to $9.97. The Waltham, Massachusetts-based drugmaker said that patients treated with T-DM1, which consists of the company’s DM1 cancer cell-killing agent, had a significant improvement in “progression-free survival.”

Limited Brands Inc. (LTD US) increased 2.9 percent to $36.25. The clothing retailer that owns Victoria’s Secret and Bath & Body Works reported same-store sales in March rose 14 percent, beating the 1.1 percent estimate by Retail Metrics Inc.

Merck & Co. (MRK US): The second-biggest U.S. drug company said it failed to win U.S. approval to expand use of the cervical-cancer vaccine Gardasil to older women.

Newmont Mining Corp. (NEM) rose 1 percent to $57. The largest U.S. gold producer plans to raise annual production of the metal to 7 million ounces by 2017 and link its dividend payment to the average sales price for the metal. The 2017 output target represents an increase of about 35 percent over the company’s 2011 forecast of 5.1 million to 5.3 million ounces.

Pep Boys - Manny, Moe & Jack (PBY US) rose 3 percent to $14.02. The Philadelphia-based auto-parts retailer reported fourth-quarter earnings excluding some items that exceeded analyst estimates and said sales increased 5.4 percent to $477.4 million.

Pier 1 Imports Inc. (PIR) rose 7.7 percent to $11.35. The home-furnishings retailer reported fourth-quarter earnings of 48 cents a share, beating the average analyst estimate by 1 cent.

Power-One Inc. (PWER) declined 1.8 percent to $8.14. The maker of electrical inverters said first-quarter sales were $245 million at most, trailing its previous forecast of at least $260 million.

Ruby Tuesday Inc. (RT) slumped 10 percent to $12. The casual-dining chain cut its 2011 earnings forecast to a range of 74 cents to 82 cents a share, from 76 cents to 87 cents a share. That’s below the average analyst projection of 91 cents a share. Inc. (CRM) climbed 1.9 percent to $133.91. The largest supplier of customer-management software was raised to “outperform” from “market perform” at FBR Capital Markets Corp.

Travelzoo Inc. (TZOO) dropped 2.7 percent to $75.80. The Internet travel marketer was cut to “hold” from “buy” at Benchmark Co.

WD-40 Co. (WDFC) : The San Diego-based maker of lubricants and hand soap cut its 2011 earnings forecast to a range from $2.23 to $2.35 a share, from $2.25 to $2.40 share. The average analyst forecast was $2.31 a share, Bloomberg data show.

XenoPort Inc. (XNPT) rallied 65 percent to $10.54. The drugmaker and GlaxoSmithKline Plc (GSK LN) won U.S. approval for a new treatment for restless legs syndrome after more than a year of delays.

Zumiez Inc. (ZUMZ) increased 1 percent to $27.77. The retailer based in Everett, Washington, said March comparable store sales increased 8.9 percent, beating the 3.2 percent estimate from Retail Metrics.

To contact the reporter on this story: Inyoung Hwang in New York at

To contact the editor responsible for this story: Nick Baker at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.